Visual prognosis and sympathetic ophthalmia.
Sympathetic ophthalmia is probably the ocular disorder best known to practitioners outside of ophthalmology. It is characterized by a bilateral, nonnecrotizing granulomatous panuveitis that occurs after intentional or unintentional trauma to the exciting eye. So far, the identity of the inciting antigen has not been delineated with certainty. The sequelae from sympathetic ophthalmia have declined markedly in this century as a result of earlier diagnosis, use of corticosteroids, and better management of ocular injuries, in large part due to improved surgical techniques. Cases of sympathetic ophthalmia, however, still occur with their severe sight-threatening complications, which impose on ophthalmologists the importance of prompt diagnosis and aggressive treatment in order to achieve good visual outcome.
Ramadan
A
A
National Eye Institute, Laboratory of Immunology, National Institutes of Health, Bethesda, MD 20892-1858, USA.
Nussenblatt
R B
RB
D006801:Humans; D009879:Ophthalmia, Sympathetic / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D011379:Prognosis; D014792:Visual Acuity